Triple

T1018336
Position Surface form Disambiguated ID Type / Status
Subject Dene E21982 entity
Predicate hasSubgroup P747 FINISHED
Object Denesuline
Denesuline are a First Nations people of the larger Dene cultural and linguistic group, traditionally inhabiting subarctic regions of northern Canada.
E119286 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Denesuline | Statement: [Dene, hasSubgroup, Denesuline]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Denesuline
Context triple: [Dene, hasSubgroup, Denesuline]
  • A. Pregny-Chambésy
    Pregny-Chambésy is a small, affluent municipality on the shores of Lake Geneva in the canton of Geneva, Switzerland, known for hosting several international organizations and diplomatic missions.
  • B. Darzalex
    Darzalex is a monoclonal antibody drug (daratumumab) used primarily in the treatment of multiple myeloma.
  • C. Versonnex
    Versonnex is a small commune in the Ain department of eastern France, located near the Swiss border in the Pays de Gex region.
  • D. Vumerity
    Vumerity is an oral prescription medication used to treat relapsing forms of multiple sclerosis in adults.
  • E. Plegridy
    Plegridy is a pegylated interferon beta-1a medication used to treat relapsing forms of multiple sclerosis.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Denesuline
Triple: [Dene, hasSubgroup, Denesuline]
Generated description
Denesuline are a First Nations people of the larger Dene cultural and linguistic group, traditionally inhabiting subarctic regions of northern Canada.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Denesuline
Target entity description: Denesuline are a First Nations people of the larger Dene cultural and linguistic group, traditionally inhabiting subarctic regions of northern Canada.
  • A. Pregny-Chambésy
    Pregny-Chambésy is a small, affluent municipality on the shores of Lake Geneva in the canton of Geneva, Switzerland, known for hosting several international organizations and diplomatic missions.
  • B. Darzalex
    Darzalex is a monoclonal antibody drug (daratumumab) used primarily in the treatment of multiple myeloma.
  • C. Versonnex
    Versonnex is a small commune in the Ain department of eastern France, located near the Swiss border in the Pays de Gex region.
  • D. Vumerity
    Vumerity is an oral prescription medication used to treat relapsing forms of multiple sclerosis in adults.
  • E. Plegridy
    Plegridy is a pegylated interferon beta-1a medication used to treat relapsing forms of multiple sclerosis.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69a493c68e24819080ed0ee8bcfd5ce0 completed March 1, 2026, 7:30 p.m.
NER Named-entity recognition batch_69a4b7c6005081909d9e56114c532d14 completed March 1, 2026, 10:03 p.m.
NED1 Entity disambiguation (via context triple) batch_69ac3bb423fc8190af65e94f8e2e75d0 completed March 7, 2026, 2:52 p.m.
NEDg Description generation batch_69ac3c8b6ce8819097f4f4d504485123 completed March 7, 2026, 2:56 p.m.
NED2 Entity disambiguation (via description) batch_69ac3cf686e48190ba49ee0b14870dcf completed March 7, 2026, 2:57 p.m.
Created at: March 1, 2026, 7:41 p.m.